These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 3315677)
1. Report on the Lipid Research Clinic trials. Levy RI Eur Heart J; 1987 Aug; 8 Suppl E():45-53. PubMed ID: 3315677 [TBL] [Abstract][Full Text] [Related]
2. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA; 1984 Jan; 251(3):351-64. PubMed ID: 6361299 [TBL] [Abstract][Full Text] [Related]
4. Lipid Research Clinics Coronary Primary Prevention Trial: results and implications. Rifkind BM Am J Cardiol; 1984 Aug; 54(5):30C-34C. PubMed ID: 6382999 [TBL] [Abstract][Full Text] [Related]
5. Dietary and other correlates of changes in total and low density lipoprotein cholesterol in hypercholesterolemic men: the lipid research clinics coronary primary prevention trial. Glueck CJ; Gordon DJ; Nelson JJ; Davis CE; Tyroler HA Am J Clin Nutr; 1986 Oct; 44(4):489-500. PubMed ID: 3532756 [TBL] [Abstract][Full Text] [Related]
6. The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study. Levy RI; Brensike JF; Epstein SE; Kelsey SF; Passamani ER; Richardson JM; Loh IK; Stone NJ; Aldrich RF; Battaglini JW Circulation; 1984 Feb; 69(2):325-37. PubMed ID: 6360415 [TBL] [Abstract][Full Text] [Related]
7. A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical events. Whitney EJ; Krasuski RA; Personius BE; Michalek JE; Maranian AM; Kolasa MW; Monick E; Brown BG; Gotto AM Ann Intern Med; 2005 Jan; 142(2):95-104. PubMed ID: 15657157 [TBL] [Abstract][Full Text] [Related]
8. Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study. Brensike JF; Levy RI; Kelsey SF; Passamani ER; Richardson JM; Loh IK; Stone NJ; Aldrich RF; Battaglini JW; Moriarty DJ Circulation; 1984 Feb; 69(2):313-24. PubMed ID: 6360414 [TBL] [Abstract][Full Text] [Related]
9. The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA; 1984 Jan; 251(3):365-74. PubMed ID: 6361300 [TBL] [Abstract][Full Text] [Related]
10. High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial. Gordon DJ; Knoke J; Probstfield JL; Superko R; Tyroler HA Circulation; 1986 Dec; 74(6):1217-25. PubMed ID: 3536151 [TBL] [Abstract][Full Text] [Related]
11. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Watts GF; Lewis B; Brunt JN; Lewis ES; Coltart DJ; Smith LD; Mann JI; Swan AV Lancet; 1992 Mar; 339(8793):563-9. PubMed ID: 1347091 [TBL] [Abstract][Full Text] [Related]
12. Secondary prevention and lipid lowering: results and implications. Detre KM; Levy RI; Kelsey SF; Epstein SE; Brensike JF; Passamani ER; Richardson JM; Loh IK; Stone NJ; Aldrich RF Am Heart J; 1985 Nov; 110(5):1123-7. PubMed ID: 3904378 [TBL] [Abstract][Full Text] [Related]
13. Pre-entry characteristics of participants in the Lipid Research Clinics' Coronary Primary Prevention Trial. J Chronic Dis; 1983; 36(6):467-79. PubMed ID: 6863470 [TBL] [Abstract][Full Text] [Related]
15. Commentary on the published results of the Lipid Research Clinics Coronary Primary Prevention Trial. Kronmal RA JAMA; 1985 Apr; 253(14):2091-3. PubMed ID: 3883022 [No Abstract] [Full Text] [Related]
16. The Lipid Research Clinics Coronary Primary Prevention Trial: results and implications. Rifkind BM Monogr Atheroscler; 1985; 13():74-84. PubMed ID: 3911061 [No Abstract] [Full Text] [Related]
17. Angiographic progression of coronary atherosclerosis in patients with familial hypercholesterolaemia treated with non-statin therapy: Impact of a fat-modified diet and a resin. Watts GF; Pang J; Chan DC; Brunt JNH; Lewis B Atherosclerosis; 2016 Sep; 252():82-87. PubMed ID: 27508319 [TBL] [Abstract][Full Text] [Related]
18. The effect of cholesterol reduction with cholestyramine on renal function. Kshirsagar AV; Shoham DA; Bang H; Hogan SL; Simpson RJ; Colindres RE Am J Kidney Dis; 2005 Nov; 46(5):812-9. PubMed ID: 16253720 [TBL] [Abstract][Full Text] [Related]
19. The Lipid Research Clinics Coronary Primary Prevention Trial. Results of 6 years of post-trial follow-up. The Lipid Research Clinics Investigators. Arch Intern Med; 1992 Jul; 152(7):1399-410. PubMed ID: 1627020 [TBL] [Abstract][Full Text] [Related]
20. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. Frick MH; Elo O; Haapa K; Heinonen OP; Heinsalmi P; Helo P; Huttunen JK; Kaitaniemi P; Koskinen P; Manninen V N Engl J Med; 1987 Nov; 317(20):1237-45. PubMed ID: 3313041 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]